Millet B
Université Rennes 1, Chu de Rennes, Hôpital Guillaume Régnier, 108 Avenue du Général Leclerc, 35000 Rennes.
Encephale. 2009 Dec;35 Suppl 7:S325-9. doi: 10.1016/S0013-7006(09)73496-7.
Electroconvulsivotherapy represents a key indication for severe Major Depressive Episode (MDE). However, an hospitalization with a general anaesthesia allowing a seizure induction followed by an almost systematic post-epileptic delirium justifies the development of other brain electrostimulation techniques. Trans-cranial Magnetic Stimulation (TMS) is a technique which offers to transform an electromagnetic field within the brain in an electric one. This therapeutic has been approved in 2008 in the MDE indication by the Food and Drug Administration. However a better knowledge of brain stimulation parameters such as the number of sequences, intensity, frequency, and the brain target, is necessary. Indeed it could enable to get some more homogeneous clinical results which will drive to the use of this technique in daily practice. Neurosurgical procedures represent also a stake for a better treatment of severe chronic and resistant depression. Whereas Vagus Nerve Stimulation (DBS) failed to be developed in France, Deep Brain Stimulation (DBS) is currently under development in this indication with some promising preliminary results.
电休克治疗是重度抑郁症发作(MDE)的关键指征。然而,因全身麻醉住院以诱发癫痫发作,随后几乎都会出现癫痫后谵妄,这促使了其他脑电刺激技术的发展。经颅磁刺激(TMS)是一种能将大脑内的电磁场转化为电场的技术。该疗法于2008年被美国食品药品监督管理局批准用于治疗重度抑郁症。然而,有必要更好地了解脑刺激参数,如序列数、强度、频率和脑靶点。实际上,这可能会带来更均匀的临床效果,从而推动该技术在日常实践中的应用。神经外科手术对于更好地治疗重度慢性难治性抑郁症也很重要。虽然迷走神经刺激(VNS)在法国未能得到发展,但深部脑刺激(DBS)目前正在该适应症领域进行研发,已取得了一些有前景的初步成果。